Zydus Pins Its Patent Loss On Co-Defendant At Fed. Circ.
Zydus urged the Federal Circuit on Tuesday to undo a ruling that the company infringed Amgen's patent on a drug used to lower calcium levels in people on dialysis, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article